Experimental cell treatment aims to ease chest pain in patients with hidden heart disease
Disease control
Terminated
This study tested a single dose of a person's own blood stem cells (CLBS16) to see if it could reduce chest pain and improve quality of life in adults with coronary microvascular dysfunction (small artery heart disease) who have angina at least three times a week. Participants ha…
Phase: PHASE2 • Sponsor: Lisata Therapeutics, Inc. • Aim: Disease control
Last updated May 06, 2026 16:03 UTC